US Patent Issued to Ligand Pharmaceuticals on Jan. 28 for "Glucagon receptor antagonists" (North Carolina, Texas, New Jersey Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,071, issued on Jan. 28, was assigned to Ligand Pharmaceuticals Inc. (San Diego).

"Glucagon receptor antagonists" was invented by Lin Zhi (Austin, Texas), Ian Henderson (Plainsboro, N.J.), Joseph Kaloko (Durham, N.C.) and Martin Osterhout (Raleigh, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are solid state forms of compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or inverse agonist activity. Further, provided herein are pharmaceutical compositions and methods of treating, preventing, ameliorating, delayin...